Tu J, Han D, Fang Y, Jiang H, Tan X, Xu Z, et al. MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes. Mol Ther Nucleic Acids. 2022;27:733-750 pubmed publisher

Pandit M, Kil Y, Ahn J, Pokhrel R, Gu Y, Mishra S, et al. Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells. Nat Commun. 2023;14:2593 pubmed publisher

Wang W, Lu J, Song Y, Zeng C, Wang Y, Yang C, et al. Repair of bone defects in rhesus monkeys with α1,3-galactosyltransferase-knockout pig cancellous bone. Front Bioeng Biotechnol. 2022;10:990769 pubmed publisher

Khatamzas E, Antwerpen M, Rehn A, Graf A, Hellmuth J, Hollaus A, et al. Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection. Nat Commun. 2022;13:5586 pubmed publisher

Shilts J, Severin Y, Galaway F, M xfc ller Sienerth N, Chong Z, Pritchard S, et al. A physical wiring diagram for the human immune system. Nature. 2022;608:397-404 pubmed publisher

Charmetant X, Espi M, Benotmane I, Barateau V, Heibel F, Buron F, et al. Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients. Sci Transl Med. 2022;14:eabl6141 pubmed publisher

Pauwels E, Rutz C, Provinciael B, Stroobants J, Schols D, Hartmann E, et al. A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide. Mol Cell Proteomics. 2021;20:100144 pubmed publisher

Goc J, Lv M, Bessman N, Flamar A, Sahota S, Suzuki H, et al. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell. 2021;184:5015-5030.e16 pubmed publisher

Tajti G, Szanto T, Csoti A, Racz G, Evaristo C, Hajdu P, et al. Immunomagnetic separation is a suitable method for electrophysiology and ion channel pharmacology studies on T cells. Channels (Austin). 2021;15:53-66 pubmed publisher

Wells D, van Buuren M, Dang K, Hubbard Lucey V, Sheehan K, Campbell K, et al. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction. Cell. 2020;183:818-834.e13 pubmed publisher

Wang L, DeRose P, Inwood S, Gaigalas A. Stochastic Reaction-Diffusion Model of the Binding of Monoclonal Antibodies to CD4 Receptors on the Surface of T Cells. Int J Mol Sci. 2020;21: pubmed publisher

Hess N, Hudson A, Hematti P, Gumperz J. Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. J Immunol. 2020;205:272-281 pubmed publisher

Lee J, Shklovskaya E, Lim S, Carlino M, Menzies A, Stewart A, et al. Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition. Nat Commun. 2020;11:1897 pubmed publisher

Zhang Y, Du X, Liu M, Tang F, Zhang P, Ai C, et al. Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy. Cell Res. 2019;29:609-627 pubmed publisher

Collinson Pautz M, Chang W, Lu A, Khalil M, Crisostomo J, Lin P, et al. Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia. 2019;: pubmed publisher

Wang Z, Zheng Q, Zhang H, Bronson R, Madsen J, Sachs D, et al. Ontak-like human IL-2 fusion toxin. J Immunol Methods. 2017;448:51-58 pubmed publisher

Vogel S, Grabski E, Buschjäger D, Klawonn F, Döring M, Wang J, et al. Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64(+) cells. Sci Rep. 2015;5:18308 pubmed publisher